Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 20, 2018

Total Value: $715M (100.0% shares, 0.0% debt)

Holdings (35)

— FOUNDATION MEDICINE INC 13.1%

Value $93.64M Shares 685,000 Est. Cost $50.19 Unrealized —

— LOXO ONCOLOGY INC 8.7%

Value $62.45M Shares 360,000 Est. Cost $28.44 Unrealized —

— BLUEPRINT MEDICINES CORP 5.6%

Value $40.31M Shares 635,000 Est. Cost $49.44 Unrealized —

— SAGE THERAPEUTICS INC 5.5%

Value $39.13M Shares 250,000 Est. Cost $52.53 Unrealized —

— MYOKARDIA INC 5.4%

Value $38.73M Shares 780,000 Est. Cost $29.88 Unrealized —

— SPARK THERAPEUTICS INC 5.4%

Value $38.32M Shares 463,000 Est. Cost $58.74 Unrealized —

— BLUEBIRD BIO INC 4.4%

Value $31.39M Shares 200,000 Est. Cost $126.58 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 4.3%

Value $30.73M Shares 364,776 Est. Cost $57.83 Unrealized +50.8%

FATE FATE THERAPEUTICS INC 4.1%

Value $29.48M Shares 2,600,000 Est. Cost $4.33 Unrealized +154.5%

CDXS CODEXIS INC 4.1%

Value $29.16M Shares 2,025,000 Est. Cost $5.90 Unrealized +120.9%

— MAGENTA THERAPEUTICS INC 3.8%

Value $27.48M Shares 2,035,818 Est. Cost $13.50 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 3.7%

Value $26.59M Shares 270,000 Est. Cost $85.55 Unrealized +15.9%

VYGR VOYAGER THERAPEUTICS INC 3.1%

Value $22.18M Shares 1,135,000 Est. Cost $14.86 Unrealized —

— GLOBAL BLOOD THERAPEUTICS IN 3.0%

Value $21.7M Shares 480,000 Est. Cost $32.45 Unrealized —

— GENMARK DIAGNOSTICS INC 3.0%

Value $21.69M Shares 3,400,000 Est. Cost $6.84 Unrealized —

ILMN ILLUMINA INC 2.8%

Value $19.97M Shares 71,500 Est. Cost $196.93 Unrealized +29.2%

SGMO SANGAMO THERAPEUTICS INC 2.8%

Value $19.88M Shares 1,400,000 Est. Cost $4.96 Unrealized +235.2%

— AUDENTES THERAPEUTICS INC 2.4%

Value $17.2M Shares 450,000 Est. Cost $19.14 Unrealized —

CRSP CRISPR THERAPEUTICS AG 1.8%

Value $12.93M Shares 220,000 Est. Cost $47.34 Unrealized +20.3%

EVH EVOLENT HEALTH INC 1.6%

Value $11.58M Shares 550,000 Est. Cost $17.59 Unrealized +7.6%

BLFS BIOLIFE SOLUTIONS INC 1.6%

Value $11.41M Shares 1,000,000 Est. Cost $9.10 Unrealized 0.0%

ONC BEIGENE LTD 1.5%

Value $10.76M Shares 70,000 Est. Cost $149.93 Unrealized —

OSUR ORASURE TECHNOLOGIES INC 1.5%

Value $10.54M Shares 640,000 Est. Cost $17.66 Unrealized -4.4%

— CLOVIS ONCOLOGY INC 1.4%

Value $10M Shares 220,000 Est. Cost $71.97 Unrealized —

EDIT EDITAS MEDICINE INC 0.9%

Value $6.39M Shares 178,333 Est. Cost $24.34 Unrealized +45.5%

NEOG NEOGEN CORP 0.7%

Value $5.212M Shares 65,000 Est. Cost $30.13 Unrealized +22.4%

CTMX CYTOMX THERAPEUTICS INC 0.7%

Value $4.743M Shares 207,500 Est. Cost $17.02 Unrealized +50.1%

— NEON THERAPEUTICS INC 0.6%

Value $4.263M Shares 338,345 Est. Cost $12.60 Unrealized —

— LOXO ONCOLOGY INC 0.5%

Value $3.47M Shares 20,000 Est. Cost $28.44 Unrealized —

ZLAB ZAI LAB LTD 0.4%

Value $3.139M Shares 135,000 Est. Cost $21.35 Unrealized —

— JOUNCE THERAPEUTICS INC 0.4%

Value $2.873M Shares 375,000 Est. Cost $18.19 Unrealized —

CDNA CAREDX INC 0.3%

Value $2.448M Shares 200,000 Est. Cost $11.47 Unrealized 0.0%

— HOMOLOGY MEDICINES INC 0.3%

Value $2.346M Shares 115,000 Est. Cost $19.51 Unrealized —

— GLOBAL BLOOD THERAPEUTICS IN 0.3%

Value $2.26M Shares 50,000 Est. Cost $32.45 Unrealized —

— BLUEPRINT MEDICINES CORP 0.1%

Value $635K Shares 10,000 Est. Cost $49.44 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	FOUNDATION MEDICINE INC	685,000	$93.64M	13.1%	$50.19	—	COM	350465100
—	LOXO ONCOLOGY INC	360,000	$62.45M	8.7%	$28.44	—	COM	548862101
—	BLUEPRINT MEDICINES CORP	635,000	$40.31M	5.6%	$49.44	—	COM	09627Y109
—	SAGE THERAPEUTICS INC	250,000	$39.13M	5.5%	$52.53	—	COM	78667J108
—	MYOKARDIA INC	780,000	$38.73M	5.4%	$29.88	—	COM	62857M105
—	SPARK THERAPEUTICS INC	463,000	$38.32M	5.4%	$58.74	—	COM	84652J103
—	BLUEBIRD BIO INC	200,000	$31.39M	4.4%	$126.58	—	COM	09609G100
AGIO	AGIOS PHARMACEUTICALS INC	364,776	$30.73M	4.3%	$57.83	+50.8%	COM	00847X104
FATE	FATE THERAPEUTICS INC	2,600,000	$29.48M	4.1%	$4.33	+154.5%	COM	31189P102
CDXS	CODEXIS INC	2,025,000	$29.16M	4.1%	$5.90	+120.9%	COM	192005106
—	MAGENTA THERAPEUTICS INC	2,035,818	$27.48M	3.8%	$13.50	—	COM	55910K108
ALNY	ALNYLAM PHARMACEUTICALS INC	270,000	$26.59M	3.7%	$85.55	+15.9%	COM	02043Q107
VYGR	VOYAGER THERAPEUTICS INC	1,135,000	$22.18M	3.1%	$14.86	—	COM	92915B106
—	GLOBAL BLOOD THERAPEUTICS IN	480,000	$21.7M	3.0%	$32.45	—	COM	37890U108
—	GENMARK DIAGNOSTICS INC	3,400,000	$21.69M	3.0%	$6.84	—	COM	372309104
ILMN	ILLUMINA INC	71,500	$19.97M	2.8%	$196.93	+29.2%	COM	452327109
SGMO	SANGAMO THERAPEUTICS INC	1,400,000	$19.88M	2.8%	$4.96	+235.2%	COM	800677106
—	AUDENTES THERAPEUTICS INC	450,000	$17.2M	2.4%	$19.14	—	COM	05070R104
CRSP	CRISPR THERAPEUTICS AG	220,000	$12.93M	1.8%	$47.34	+20.3%	NAMEN AKT	H17182108
EVH	EVOLENT HEALTH INC	550,000	$11.58M	1.6%	$17.59	+7.6%	CL A	30050B101
BLFS	BIOLIFE SOLUTIONS INC	1,000,000	$11.41M	1.6%	$9.10	0.0%	COM NEW	09062W204
ONC	BEIGENE LTD	70,000	$10.76M	1.5%	$149.93	—	SPONSORED ADR	07725L102
OSUR	ORASURE TECHNOLOGIES INC	640,000	$10.54M	1.5%	$17.66	-4.4%	COM	68554V108
—	CLOVIS ONCOLOGY INC	220,000	$10M	1.4%	$71.97	—	COM	189464100
EDIT	EDITAS MEDICINE INC	178,333	$6.39M	0.9%	$24.34	+45.5%	COM	28106W103
NEOG	NEOGEN CORP	65,000	$5.212M	0.7%	$30.13	+22.4%	COM	640491106
CTMX	CYTOMX THERAPEUTICS INC	207,500	$4.743M	0.7%	$17.02	+50.1%	COM	23284F105
—	NEON THERAPEUTICS INC	338,345	$4.263M	0.6%	$12.60	—	COM	64050Y100
—	LOXO ONCOLOGY INC	20,000	$3.47M	0.5%	$28.44	—	Put	548862101
ZLAB	ZAI LAB LTD	135,000	$3.139M	0.4%	$21.35	—	ADR	98887Q104
—	JOUNCE THERAPEUTICS INC	375,000	$2.873M	0.4%	$18.19	—	COM	481116101
CDNA	CAREDX INC	200,000	$2.448M	0.3%	$11.47	0.0%	COM	14167L103
—	HOMOLOGY MEDICINES INC	115,000	$2.346M	0.3%	$19.51	—	COM	438083107
—	GLOBAL BLOOD THERAPEUTICS IN	50,000	$2.26M	0.3%	$32.45	—	Put	37890U108
—	BLUEPRINT MEDICINES CORP	10,000	$635K	0.1%	$49.44	—	Call	09627Y109